Linda Yaccarino

CEO of eMed Population Health, Mom, foodie, fashion enthusiast, @penn_state alum, former CEO of X

[Linda Yaccarino @lindayaX]

@Eric_Schmitt AMEN🙏

[Linda Yaccarino @lindayaX]

@JohnnaCrider1 Love

[Linda Yaccarino @lindayaX]

@theallinpod @JensenHuang @satyanadella @rookisaacman @Gwynne_Shotwell 🔥

[Miranda Devine @mirandadevine]

This is a masterclass in eloquent integrity to neutralize media tricks. @SecTurnerPress

[Linda Yaccarino @lindayaX]

@NBCOlympics wow

[Linda Yaccarino @lindayaX]

@japan_nobunaga worth following this account!! love it

[Linda Yaccarino @lindayaX]

@SawyerMerritt @Starlink literally game changing. will be a deiciding factor for many

[Linda Yaccarino @lindayaX]

@MarindaVannoy1 🫶

[Linda Yaccarino @lindayaX]

@harleyf @jimcramer @MadMoneyOnCNBC congrats! 🔥

[Linda Yaccarino @lindayaX]

@APompliano 🫡

[Linda Yaccarino @lindayaX]

@PalmerLuckey msm typical operating procedure

[Linda Yaccarino @lindayaX]

@Johnny_Joey May God’s peace comfort you. He has a plan!

[Linda Yaccarino @lindayaX]

Bank of America CEO Brian Moynihan is right to raise the question of GLP-1 costs.
But here's the bigger question every employer should be asking: What's the cost of doing nothing?
Chronic disease is already one of the largest costs facing employers.
The medication is the catalyst, not the strategy.
The organizations that win will focus on outcomes, adherence, and long-term health, not just pharmacy spend. For the first time, employers have the opportunity to pursue a health solution and a financial solution.
For the first time, employers have the opportunity to pursue a health solution and a financial solution at the same time. That's exactly what we are building at eMed.

[unusual_whales @unusual_whales]

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO has said

[Linda Yaccarino @lindayaX]

Bank of America CEO Brian Moynihan is right to raise the question of GLP-1 costs.
But here's the bigger question every employer should be asking: What's the cost of doing nothing?
Chronic disease is already one of the largest costs facing employers.
The medication is the catalyst, not the strategy.
The organizations that come out ahead will focus on outcomes, adherence, and long-term health, not just pharmacy spend.
https://t.co/PNeZebIpEU

[Linda Yaccarino @lindayaX]

yes!

[Alexis Ohanian 🗽 @alexisohanian]

Stay optimistic

[Linda Yaccarino @lindayaX]

@femalequotient incredible

[Linda Yaccarino @lindayaX]

@EagleEdMartin 🔥

[Linda Yaccarino @lindayaX]

We've just scratched the surface of what these drugs can do. Diabetes, weight loss, and now potentially alcohol disorder too, with veterans one of the key groups being studied.
The through-line isn't the condition. It's what happens when people stay on the medication long enough to see the full effect.
Happy to work directly with veterans and the government on this.

[Linda Yaccarino @lindayaX]

@MarindaVannoy1 @RSFitz sickeningly real!!

[Linda Yaccarino @lindayaX]

What a day at the @whitehouse celebrating the dynasty known as @pennstateWrest. Thank you @POTUS.
WeAre!💙🤍 @JohnFetterman @NoBickal @SenMcCormickPA @caelsanderson

[Penn State Wrestling @PennStateWREST]

We are honored and grateful for the opportunity to visit The White House🇺🇸

Thank you for the warm hospitality, and for making this an incredible experience for our student-athletes and staff!

#PSUwr